AN 448 SANDOZ (MAZINDOL) IN THE TREATMENT OF OBESITY
- 1 July 1962
- journal article
- clinical trial
- Published by AMPCo in The Medical Journal of Australia
- Vol. 1 (11) , 343-345
- https://doi.org/10.5694/j.1326-5377.1976.tb140662.x
Abstract
The clinical value of a new anorectic agent, AN 448 Sandoz (mazindol) has been assessed in a double-blind trial against placebo in 50 obese patients. Over the 12 weeks of the trial, mazindol was shown to be an effective adjunct to carbohydrate restriction in weight reduction.Keywords
This publication has 0 references indexed in Scilit: